Two upcoming live webinars reflect ISMA’s commitment to educating physicians about caring for individuals who are leaving incarceration and those dealing with opioid use disorder (OUD). On Thursday, Feb. 2, Cameual Wright, MD, MBA, will present “Engagement, Empowerment and Equity: Best Practices in Caring for Justice-Involved Patients.” And the 2023 Opioid CME Series continues Thursday, Feb. 9, with “Treating Opioid Use Disorder: A Review of FDA Approved Medications and Buprenorphine Prescribing Requirements,” presented by Michael A. Mitcheff, DO, MBA.
|
![](/images/e-reports/2023/Cameual-Wright_image.jpg) |
|
Cameual Wright, MD, MBA
CareSource Indiana
|
Engagement, Empowerment and Equity: Best Practices in Caring for Justice-Involved Patients
Accredited for 1.0
AMA PRA Category 1 Credits™
Thursday, Feb. 2
Noon – 1 p.m. ET
Free for members; nonmembers $75
Registration required
The rate of recidivism for incarcerated individuals in the United States is 70% within five years of release, with few resources to assist reentering individuals in finding housing, gaining employment or accessing social services. In this webinar,
Cameual Wright, MD, MBA, of CareSource Indiana, will discuss the myriad challenges that individuals face when they leave incarceration, how CareSource serves them, and how physicians play a critical role in meeting the complex needs of reentering individuals.
REGISTER NOW >>
Treating Opioid Use Disorder: A Review of FDA Approved Medications and Buprenorphine Prescribing Requirements
Accredited for 1.0
AMA PRA Category 1 Credits™
Thursday, Feb. 9
Noon – 1 p.m. ET
Registration required
The 2023 Live Opioid CME Series is FREE for members and nonmembers thanks to support by a State Opioid Response Grant from:
|
Indiana Family and Social Services Administration
Division of Mental Health and Addiction |
|
![](/images/e-reports/2023/Mitcheff.jpg) |
|
Michael A Mitcheff, DO, MBA, CHCQM
Wexford Health Sources
Beacon Addiction Medicine LLC
|
In spite of the extensive evidence supporting the use of medications to treat OUD, there remain major gaps in knowledge about which medication works best and for whom, as well as how the medications compare over the long term. This webinar, led by
Michael A. Mitcheff, DO, MBA, CHCQM, corporate medical director of Wexford Health Sources and chief medical officer of Beacon Addiction Medicine LLC, will give physicians and nonphysician practitioners a better understanding of functional outcomes of medication-based treatment for OUD.
Please note: Recordings of each webinar in the series will be posted to the ISMA Online mobile app for on-demand viewing. ISMA members automatically receive free access to the entire ISMA Online library of archived content and accredited CME courses.
Nonmember physicians may subscribe to ISMA Online and all archived content through Dec. 31, 2023, for $400 – or join ISMA to receive this and other valuable benefits of membership. Learn more >>
REGISTER NOW >>
About the 2023 Opioid CME Series
Each webinar in this series counts toward the 2.0 hours of CME on opioid prescribing or abuse required to renew a Controlled Substances Registration in Indiana by the Oct. 31, 2023, deadline. Additional sessions will focus on women and addiction, novel drugs of abuse, opioids and the emergency department, and other timely topics.
Registration for future live webinars in the series is now open at www.ismanet.org/events.
Nonphysician practitioners: APRNs and PAs are able to register for webinars in the FREE Live Opioid CME Series as well.
Nonmembers: To register, nonmembers must first create a user account by going to the ISMA website and taking the following steps:
- Click or tap “Sign In” in upper right corner of webpage.
- When prompted for username and password, click or tap on “Create an account”
![](/images/e-reports/2023/createaccount.png)
- Follow the steps as directed from there for required fields.